Over The Counter OTC Pain Relievers

Over The Counter OTC Pain Relievers Market Outlook

The global Over The Counter (OTC) pain relievers market is projected to reach USD 45 billion by 2035, growing at a CAGR of 5.5% during the forecast period of 2025-2035. This growth can be attributed to the increasing prevalence of chronic pain conditions, coupled with the rising consumer inclination towards self-medication for managing mild to moderate pain. Furthermore, the ongoing shift toward preventive healthcare and wellness, alongside the growing awareness amongst consumers about the benefits of OTC medication, is driving market expansion. Additionally, the increasing availability of these products in various retail formats, including online platforms, is enhancing accessibility for consumers. As a result, the market is experiencing a significant boost, with more individuals opting for convenient and effective pain relief solutions.

Growth Factor of the Market

The growth of the OTC pain relievers market is primarily fueled by several key factors, including the increase in lifestyle-related disorders and an aging population that experiences higher incidences of pain-related issues. The convenience of purchasing OTC medications without a prescription also plays a crucial role in driving demand. Moreover, the growing emphasis on consumer education regarding proper pain management strategies has led to increased confidence in self-medication. The impact of marketing strategies that highlight the efficacy and safety of OTC pain relievers has further contributed to their popularity. Additionally, advancements in packaging and formulation, such as fast-dissolving tablets and liquid gels, have made these products more appealing to consumers, thus propelling market growth.

Key Highlights of the Market

• The OTC pain relievers market is expected to experience considerable growth due to rising consumer awareness about self-medication.
• Chronic pain conditions, including arthritis and back pain, are major contributors to the demand for OTC pain relief products.
• Growing e-commerce platforms are enhancing the accessibility of OTC medications to a broader audience.
• Innovations in product formulations are leading to the development of more effective and user-friendly pain relief solutions.
• The market is characterized by a competitive landscape with a mix of established players and emerging companies striving for market share.

By Product Type

Acetaminophen:

Acetaminophen is one of the most commonly used OTC pain relievers, known for its effectiveness in treating mild to moderate pain such as headaches, muscle aches, and fever. It operates primarily through the inhibition of prostaglandin synthesis in the brain, offering a safer alternative to non-steroidal anti-inflammatory drugs (NSAIDs) for individuals who may be sensitive to such medications. The product's widespread availability and lack of severe side effects, when used as directed, contribute to its popularity among consumers. Additionally, acetaminophen is often recommended for pediatric use due to its favorable safety profile, further driving its market growth.

Ibuprofen:

Ibuprofen is a widely used NSAID that provides effective relief for pain and inflammation associated with conditions such as arthritis and menstrual cramps. Its dual action of reducing both pain and inflammation makes it a preferred choice for many patients. The ability to take ibuprofen in various forms—such as tablets, liquid gels, and topical applications—enhances its appeal. Moreover, the growing awareness about the benefits of ibuprofen, combined with effective marketing strategies, has significantly increased its consumption. The convenience of accessibility in pharmacies and supermarkets also contributes to its strong market presence.

Aspirin:

Aspirin is another well-known OTC pain reliever that has been utilized for decades. It is often used to relieve mild pain, reduce inflammation, and lower fever. Additionally, aspirin is recognized for its cardioprotective properties, making it a popular choice among individuals seeking long-term pain management solutions, particularly for those with a history of cardiovascular issues. Its role in the prevention of heart attacks further solidifies its position in the OTC market. However, the potential for gastrointestinal side effects may deter some consumers, leading to a need for clear consumer education regarding its safe use.

Naproxen:

Naproxen is an effective OTC pain reliever commonly used for conditions such as arthritis, muscle pain, and menstrual cramps. It provides longer-lasting relief compared to other NSAIDs, making it an attractive option for patients dealing with chronic pain. Its anti-inflammatory properties, along with a relatively low risk of gastrointestinal side effects compared to aspirin, have contributed to its growing adoption. Additionally, the increasing prevalence of lifestyle-related disorders is expected to drive the demand for naproxen, enhancing its market share within the OTC pain relievers segment.

Ketoprofen:

Ketoprofen is a lesser-known NSAID that is gaining traction in the OTC pain relievers market due to its effectiveness in managing pain and inflammation. It is particularly useful for treating osteoarthritis and rheumatoid arthritis. Ketoprofen's dual action—providing both analgesic and anti-inflammatory effects—positions it as a competitive option against other NSAIDs. As consumers become more aware of the benefits of ketoprofen, particularly for chronic conditions, its market presence is expected to increase. Education and promotional efforts highlighting its benefits and safe use will be crucial to driving its adoption.

By Application

Muscle Pain:

Muscle pain is a common complaint among individuals of all ages, whether resulting from physical activity, sports injuries, or chronic conditions. The demand for OTC pain relievers specifically targeting muscle pain is significant, as consumers seek quick and effective relief without the need for a prescription. Products containing NSAIDs, such as ibuprofen and naproxen, are widely used for this purpose due to their anti-inflammatory properties, which help alleviate pain and reduce swelling. The growing trend of fitness and wellness, coupled with an increase in active lifestyles, is expected to further boost the consumption of OTC pain relievers aimed at muscle pain relief.

Headache:

Headaches are one of the most prevalent types of pain experienced by individuals across the globe. The OTC pain relievers market has a strong focus on headache relief products, with acetaminophen and ibuprofen being the most commonly used options. As headaches can be triggered by various factors, including stress, dehydration, and tension, the demand for accessible and effective solutions is high. The increasing incidence of headaches due to lifestyle changes, such as prolonged screen time and lack of sleep, is expected to propel growth in this segment. As a result, manufacturers are focusing on developing specialized formulations to cater to consumers seeking effective headache relief.

Arthritis:

Arthritis is a chronic condition that affects millions of people worldwide, leading to persistent pain and inflammation in joints. This has created a substantial demand for OTC pain relievers that can provide effective long-term management options. Products containing naproxen and ibuprofen are particularly favored for their anti-inflammatory properties, making them suitable for arthritis relief. The increasing aging population, which is more susceptible to arthritis, further drives this market segment. Moreover, the continuous development of formulations aimed at improving the efficacy and safety of these medications is expected to enhance their appeal to consumers dealing with arthritis pain.

Menstrual Pain:

Menstrual pain, or dysmenorrhea, is a common issue affecting many women of reproductive age. The OTC pain relievers market caters to this demographic with products specifically formulated to alleviate menstrual discomfort. Ibuprofen and naproxen are frequently recommended for their proven effectiveness in reducing menstrual cramps. The rising awareness of women's health issues and the growing acceptance of self-medication have resulted in increased sales of OTC pain relievers for menstrual pain. Furthermore, the introduction of products with added benefits, such as herbal ingredients that promote relaxation, is gaining traction, providing consumers with more options for managing menstrual pain.

Back Pain:

Back pain is one of the leading causes of disability globally, significantly impacting quality of life. The OTC pain relievers market has seen substantial growth in this segment as individuals seek relief from acute and chronic back pain without the need for prescriptions. NSAIDs such as ibuprofen are commonly used due to their anti-inflammatory effects. The increasing prevalence of sedentary lifestyles and ergonomic issues in the workplace has contributed to the rise in back pain complaints, further driving market demand for effective OTC pain relief solutions. Manufacturers are focusing on creating specialized products and formulations targeting back pain to meet the needs of this large consumer base.

By Distribution Channel

Pharmacies:

Pharmacies are a primary distribution channel for OTC pain relievers, offering consumers convenient access to a broad range of products. The presence of trained pharmacists allows consumers to seek guidance and recommendations tailored to their needs, enhancing trust in the selected products. Pharmacies often promote specific brands or formulations through in-store displays and marketing campaigns, which can influence consumer purchasing decisions. The reliability and ease of accessing pain relief solutions at local pharmacies contribute significantly to the continued growth of this distribution channel in the OTC pain relievers market.

Drug Stores:

Drug stores have emerged as a vital distribution channel for OTC pain relievers, boasting extensive product selections and competitive pricing. These stores often feature dedicated sections for pain relief products, making it easier for consumers to locate their preferred medications. The convenience of purchasing OTC medications alongside other health and wellness products further enhances the shopping experience. Additionally, drug stores frequently engage in promotional activities to attract consumers, such as discounts and loyalty programs, thereby driving sales in this segment. As a result, drug stores are expected to maintain a strong foothold in the OTC pain relievers market.

Online Retailers:

The rise of e-commerce has transformed the distribution landscape for OTC pain relievers, providing consumers with a convenient and discreet option for purchasing medications. Online retailers offer extensive product ranges, often at competitive prices, making it easier for consumers to find specific pain relief solutions. The growth of home delivery services and subscription models has further enhanced the appeal of online shopping. Additionally, the availability of customer reviews and ratings on e-commerce platforms helps consumers make informed purchasing decisions. This channel's increasing popularity highlights the importance of online retail in the overall OTC pain relievers market.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets serve as a significant distribution channel for OTC pain relievers, providing consumers with the convenience of one-stop shopping. These large retail formats typically offer a wide variety of OTC medications, catering to diverse consumer needs. The competitive pricing and promotional deals frequently available in supermarkets and hypermarkets attract consumers seeking value for their money. Additionally, the ability to purchase pain relief products alongside grocery and household items enhances convenience, encouraging impulse purchases. The continued expansion of supermarket chains into new regions is likely to further support the growth of the OTC pain relievers market.

By Ingredient Type

NSAIDs:

Non-steroidal anti-inflammatory drugs (NSAIDs) are a prominent ingredient group in the OTC pain relievers market, known for their effectiveness in reducing pain and inflammation. Common NSAIDs, such as ibuprofen and naproxen, are widely utilized for various pain relief applications, including headaches and arthritis. The broad acceptance of NSAIDs among consumers is driven by their proven efficacy and availability without a prescription. As awareness of pain management options increases, the demand for NSAIDs in the OTC market is expected to grow. Continuous research and development efforts focused on improving the safety and efficacy profiles of NSAIDs will also play a critical role in enhancing their market presence.

Salicylates:

Salicylates, which include aspirin, are commonly used in OTC pain relief medications. They work by inhibiting the production of substances that mediate inflammation and pain. Salicylates are often favored for their dual action of relieving pain and providing antipyretic effects. The market for salicylate-based pain relievers is bolstered by the increasing recognition of aspirin's cardiovascular benefits, leading to a dual-purpose market for pain relief and heart health. Despite the potential side effects associated with long-term use, ongoing consumer education and marketing efforts are likely to maintain their demand within the OTC pain relievers market.

Acetaminophen:

Acetaminophen is a widely used analgesic and antipyretic agent, popular in the OTC pain relievers market. Its reputation for safety, particularly in pediatric use, has made it a preferred choice among parents and caregivers for managing mild to moderate pain and reducing fever. The versatility of acetaminophen, available in various formulations such as tablets, liquids, and dissolvable formats, caters to diverse consumer preferences. Furthermore, as more individuals seek effective pain management solutions without the side effects associated with NSAIDs, the market for acetaminophen is likely to expand significantly in the coming years.

Muscle Relaxants:

Muscle relaxants are gaining traction in the OTC pain relievers market, particularly for individuals seeking relief from muscle spasms and discomfort. Products that combine analgesic properties with muscle relaxants are appealing to consumers dealing with acute muscle pain or strain. The growing interest in the wellness industry, alongside an increasing focus on physical fitness, has led to a rise in the demand for muscle relaxants. As more consumers turn to OTC solutions for comprehensive pain relief, the market for muscle relaxants is expected to experience notable growth in conjunction with other pain relief ingredients.

Topical Analgesics:

Topical analgesics are a unique category within the OTC pain relievers market, offering localized relief for conditions such as joint pain, muscle soreness, and neuropathic pain. These products, which include creams, gels, and patches, provide consumers with the advantage of targeted application, minimizing systemic side effects associated with oral medications. The increasing prevalence of conditions requiring localized pain management, combined with the convenience of use associated with topical analgesics, is driving demand in this segment. As consumers seek alternative and complementary options for pain management, the market for topical analgesics is expected to grow significantly.

By Region

North America stands as one of the leading regions in the OTC pain relievers market, driven primarily by the high prevalence of chronic pain conditions and the increased adoption of self-medication practices. The market in North America is projected to grow at a CAGR of 5.2% during the forecast period, fueled by the rising awareness of pain management strategies and the availability of a wide range of OTC pain relief products. The presence of established pharmaceutical companies and robust distribution networks further contribute to the region's dominance in this market. The growing trend of e-commerce and online purchasing of OTC medications is also expected to bolster market growth in North America.

In Europe, the OTC pain relievers market is also witnessing substantial growth, primarily due to a rising aging population and increasing incidences of lifestyle-related disorders. The European market is expected to expand at a CAGR of 4.8%, driven by the growing emphasis on preventive healthcare and wellness. Additionally, the increased availability of pain relief solutions through pharmacies, supermarkets, and online platforms enhances accessibility for consumers. Countries such as Germany, the UK, and France are key players in the European OTC pain relievers market, significantly contributing to its overall growth and development.

Opportunities

The OTC pain relievers market offers numerous opportunities for growth, particularly as consumer attitudes toward self-medication continue to evolve. With the increasing prevalence of chronic pain conditions, there is a growing demand for effective and easily accessible pain relief solutions. Manufacturers can capitalize on this trend by developing innovative formulations, such as fast-acting gels or combination products that address multiple pain types simultaneously. The expansion of online retailing also presents an opportunity for companies to reach a wider audience, especially among tech-savvy consumers who prefer the convenience of online shopping. Additionally, the rise of wellness and holistic health trends may lead to increased interest in natural and herbal pain relief alternatives, allowing companies to diversify their product offerings.

Furthermore, targeted marketing campaigns aimed at specific demographics, such as the elderly or athletes, can enhance brand visibility and foster customer loyalty. Education initiatives that inform consumers about proper pain management techniques and the safe use of OTC medications can also create opportunities for growth. Collaborations with healthcare professionals and wellness influencers may enhance brand credibility and drive sales. As the market continues to expand, companies that adapt to consumer preferences and invest in research and development will be well-positioned to take advantage of these emerging opportunities.

Threats

Despite the significant growth potential of the OTC pain relievers market, several threats could impact its trajectory. The increasing competition from prescription pain medications, particularly in cases of chronic pain management, poses a challenge for OTC products. Some consumers may be inclined to seek stronger prescription options, especially if they do not find sufficient relief from OTC medications. Additionally, the potential for adverse side effects and misuse of OTC pain relievers could lead to increased scrutiny from regulatory authorities, resulting in stricter regulations and limits on marketing practices. Consumer concerns regarding the safety of long-term usage of certain ingredients, such as NSAIDs and salicylates, may also hinder market growth.

Moreover, the rising trend of alternative therapies and natural remedies can be seen as a threat to the traditional OTC pain relievers market, as more consumers seek holistic approaches to pain management. Increased awareness of potential side effects associated with long-term use of OTC medications may lead to a decline in consumer trust. Manufacturers must remain vigilant in addressing these threats by ensuring product safety, providing clear labeling, and actively engaging in consumer education regarding the responsible use of OTC pain relievers. Failure to address these threats could result in a loss of market share to alternative health solutions.

Competitor Outlook

• Johnson & Johnson
• Pfizer Inc.
• Bayer AG
• GlaxoSmithKline plc
• Advil (Walgreens Boots Alliance, Inc.)
• Tylenol (McNeil Consumer Healthcare)
• Rite Aid Corporation
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Novartis AG
• Himalaya Drug Company
• Amgen Inc.
• Church & Dwight Co., Inc.
• Spectrum Brands Holdings, Inc.
• Nestlé S.A.

The competitive landscape of the OTC pain relievers market is characterized by a mix of established pharmaceutical giants and emerging players striving for market penetration. Major players like Johnson & Johnson, Pfizer, and Bayer dominate the market due to their extensive product portfolios, strong brand recognition, and robust distribution networks. These companies continuously invest in research and development to enhance product formulations and address diverse consumer needs, allowing them to maintain a competitive edge in the ever-evolving market. Additionally, aggressive marketing strategies and promotional campaigns are employed by these key players to strengthen their market presence and capture the attention of consumers.

Emerging companies are also making their mark in the OTC pain relievers market, often focusing on niche segments or innovative formulations that cater to specific consumer demographics. The rise of e-commerce has enabled these smaller players to reach a broader audience without significant investment in physical retail spaces. As consumers increasingly opt for online shopping, these emerging companies leverage digital marketing and social media channels to engage with their target markets effectively. Collaboration with healthcare professionals and influencers is becoming a common strategy to build credibility and trust among consumers.

Among the major companies, Johnson & Johnson stands out with its extensive portfolio of well-known brands, including Tylenol and Motrin. The company focuses on innovation and sustainability, aligning its product offerings with evolving consumer preferences. Pfizer, with its Advil brand, has established itself as a trusted name in the pain relief segment, continually developing new formulations to meet consumer demands. Bayer's Aspirin brand remains a leading player in the market, capitalizing on its established reputation for effective pain relief and cardiovascular health. As the OTC pain relievers market continues to grow, the competitive dynamics will be shaped by innovations, marketing strategies, and consumer preferences.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Bayer AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Amgen Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Novartis AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Pfizer Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Sanofi S.A.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Johnson & Johnson
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Nestlé S.A.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 GlaxoSmithKline plc
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Rite Aid Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Himalaya Drug Company
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Church & Dwight Co., Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Reckitt Benckiser Group plc
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Spectrum Brands Holdings, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Tylenol (McNeil Consumer Healthcare)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Advil (Walgreens Boots Alliance, Inc.)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Over The Counter OTC Pain Relievers Market, By Application
    • 6.1.1 Muscle Pain
    • 6.1.2 Headache
    • 6.1.3 Arthritis
    • 6.1.4 Menstrual Pain
    • 6.1.5 Back Pain
  • 6.2 Over The Counter OTC Pain Relievers Market, By Product Type
    • 6.2.1 Acetaminophen
    • 6.2.2 Ibuprofen
    • 6.2.3 Aspirin
    • 6.2.4 Naproxen
    • 6.2.5 Ketoprofen
  • 6.3 Over The Counter OTC Pain Relievers Market, By Distribution Channel
    • 6.3.1 Pharmacies
    • 6.3.2 Drug Stores
    • 6.3.3 Online Retailers
    • 6.3.4 Supermarkets/Hypermarkets

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Over The Counter OTC Pain Relievers Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Over The Counter OTC Pain Relievers market is categorized based on

By Product Type

• Acetaminophen
• Ibuprofen
• Aspirin
• Naproxen
• Ketoprofen

By Application

• Muscle Pain
• Headache
• Arthritis
• Menstrual Pain
• Back Pain

By Distribution Channel

• Pharmacies
• Drug Stores
• Online Retailers
• Supermarkets/Hypermarkets

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Johnson & Johnson
• Pfizer Inc.
• Bayer AG
• GlaxoSmithKline plc
• Advil (Walgreens Boots Alliance, Inc.)
• Tylenol (McNeil Consumer Healthcare)
• Rite Aid Corporation
• Reckitt Benckiser Group plc
• Sanofi S.A.
• Novartis AG
• Himalaya Drug Company
• Amgen Inc.
• Church & Dwight Co., Inc.
• Spectrum Brands Holdings, Inc.
• Nestlé S.A.